What Initiates Inflammation In Acute Psgn?

Acute post-streptococcal glomerulonephritis, or APSGN, is a kidney condition that can develop after certain streptococcus infections. The inflammation in APSGN does not come from the bacteria attacking the kidney directly. Instead, it is triggered by the body’s own immune response. Immune proteins and complement factors get deposited inside the kidney’s filtering units, and that deposition sets off the inflammation.

What Initiates Inflammation In Acute Psgn?

Inflammation in APSGN begins when immune complexes form and lodge in the glomeruli, the tiny filtering units inside the kidney. These complexes are made of antibodies bound to streptococcal antigens — proteins from the bacteria. Once they settle in the glomerulus, they activate the complement system, a group of immune proteins that drive inflammation.

The infection itself usually happens somewhere else in the body, most often the throat or the skin. The kidneys are not infected. They become collateral damage in an immune reaction that was meant to target the bacteria.

This distinction matters. APSGN is not an infection of the kidney. It is an immune-mediated injury. That is why antibiotics treat the original strep infection but do not stop the kidney inflammation once it has started.

Which Streptococcal Infections Lead To APSGN?

Only certain strains of group A streptococcus cause APSGN. These are called nephritogenic strains, meaning they have the capacity to trigger kidney inflammation. Most strep infections do not.

The two most common triggers are strep throat and streptococcal skin infections, such as impetigo. Strep throat tends to be the more common trigger in colder climates, while skin infections are more often the source in warmer regions.

Not everyone who gets one of these infections develops APSGN. Most people do not. The reasons why some people develop it and others do not are not fully understood, but genetics and individual immune responses are thought to play a role.

How Does The Immune Response Damage The Kidney?

The damage is a case of misdirected immunity. When the body fights a strep infection, it makes antibodies against streptococcal proteins. Those antibodies bind to antigens still circulating in the blood, forming immune complexes.

Normally, the body clears these complexes. In APSGN, some of them get trapped in the glomeruli. The glomerulus is a bundle of tiny blood vessels that filters waste from blood into urine. Its structure — a dense network of capillaries with small pores — makes it a natural place for circulating complexes to settle.

Once deposited, the complexes activate complement proteins. Complement is part of the innate immune system, and one of its jobs is to flag and destroy foreign material. When activated inside the glomerulus, complement proteins recruit inflammatory cells and increase the permeability of the capillary walls. This is what produces the characteristic findings of APSGN: blood and protein leaking into the urine, and reduced filtration capacity.

Some research also points to a process called molecular mimicry, where antibodies against strep proteins accidentally recognize similar proteins in the kidney. The evidence for this mechanism in APSGN is not as strong as it is in rheumatic fever, another post-streptococcal condition. The immune complex deposition model is better established.

What Are The Symptoms Of Acute PSGN?

Symptoms typically appear one to two weeks after a throat infection, or three to six weeks after a skin infection. The delay reflects the time needed for the immune response to build and for complexes to deposit in the kidney.

The most noticeable sign is often dark or cola-colored urine, caused by blood passing through damaged glomeruli. Other common symptoms include:

• Swelling in the face, especially around the eyes, and in the hands and feet
• Reduced urine output
• Fatigue
• Elevated blood pressure
• Foamy urine, from protein leaking through damaged filters

Some people develop only mild symptoms and may not seek medical attention. Others develop more significant swelling and hypertension. In severe cases, which are uncommon, breathing difficulty can occur due to fluid buildup in the lungs.

APSGN is more common in children than adults. When it does occur in adults, it tends to be more severe.

How Is APSGN Diagnosed?

Diagnosis relies on a combination of clinical signs, urine testing, blood tests, and evidence of recent strep infection.

Urinalysis typically shows blood and protein in the urine. Red blood cell casts — clumps of red blood cells shaped by the kidney tubules — are a particularly strong indicator of glomerular inflammation.

Blood tests measure kidney function, usually through creatinine and estimated glomerular filtration rate. Complement levels, particularly C3, are often low during the acute phase. A low C3 that later normalizes is a pattern consistent with APSGN.

Evidence of recent strep infection can be confirmed through throat or skin cultures, or through antibody tests such as anti-streptolysin O and anti-DNase B. These tests show that the immune system recently encountered group A streptococcus.

In most cases, a kidney biopsy is not needed. It may be considered when the diagnosis is unclear or when the course of illness is unusual.

How Is Acute PSGN Treated?

There is no specific treatment that reverses the immune complex deposition. Management focuses on controlling symptoms and supporting kidney function while the inflammation resolves on its own.

Blood pressure control is a priority because hypertension can worsen kidney damage. Dietary sodium restriction and, when needed, blood pressure medications are commonly used. Diuretics may be prescribed to reduce swelling and fluid overload.

Antibiotics are given if there is still an active strep infection. They do not change the course of the kidney inflammation once it has begun, but they reduce the risk of spreading the infection to others.

Most children recover fully. Kidney function typically returns to normal within weeks to months. Adults have a higher risk of persistent kidney problems, though long-term complications are still uncommon.

The evidence on long-term outcomes in adults is less clear than in children. Some studies suggest a higher rate of chronic kidney disease after APSGN in adults, but the data are not consistent across all populations.

Can APSGN Be Prevented?

Prevention means preventing the strep infection in the first place, or treating it promptly. Prompt antibiotic treatment of strep throat reduces the risk of APSGN, though it does not eliminate it entirely.

The evidence for antibiotic treatment preventing APSGN from skin infections is weaker. Skin infections are often not diagnosed or treated as quickly as throat infections.

There is no vaccine currently available for group A streptococcus. Research into vaccines is ongoing, but no approved product exists. Hand hygiene and avoiding close contact with people who have active strep infections can reduce transmission.

It is worth noting that APSGN is not contagious in itself. The strep infection that precedes it is contagious, but the kidney condition is not.